News summary
the Zhongguancunmostpopularblockchaingames: The application for drug registration of Ambroxol Hydrochloride Injection, a subsidiary company, was accepted Securities Times e Company NewsmostpopularblockchaingamesZhongguancun (000931) announced on the evening of April 29 that Duoduo Pharmaceutical, a subsidiary of the company, recently received a chemical generic drug ambroxol hydrochloride issued by the State Food and Drug Administrationmostpopularblockchaingames.mostpopularblockchaingames..
Newsletter text
Zhongguancun: Its subsidiary company Duoduo Pharmaceutical's drug registration application for ambroxol hydrochloride injection was accepted. Securities Times Company e News, Zhongguancun (000931) announced on the evening of April 29 that its subsidiary company Duoduo Pharmaceutical recently received the State Drug Administration. Notice of acceptance of the application for drug registration of the chemical generic ambroxol hydrochloride injection. Ambroxol hydrochloride injection is suitable for the expectorant treatment of acute and chronic lung diseases accompanied by abnormal sputum secretion and poor expectoration function, such as acute exacerbation of chronic bronchitis, wheezing bronchitis and bronchial asthma.
